COVID-19 Clinical Management Workshop 2020
Related Enduring Materials
Enduring Materials
Session 1: From Basic Knowledge to Optimal Clinical Management -
Session chairs
19:05 CET
Virology – Drug Targets for Therapeutic Intervention
19:25 CET
Antivirals Therapy for COVID-19
19:45 CET
Convalescent Plasma for COVID-19. Late, Early or Never?
20:05 CET
Clinical Spectrum of COVID-19
20:25 CET
Roundtable Discussion and Q&A
20:45 CET
End of Day 1
Day 2 - Tuesday, 15 December 2020
Session 2: Helping the Body - Immuno Regulatory interventions -
Rajesh Gandhi, MD
Session chairs
19:00 CET
What Causes the Cytokine Storm in SARS-CoV-2?
19:20 CET
Corticosteroids in the Treatment of COVID-19
Massachusetts General Hospital, Harvard University Center for AIDS Research, United States
19:40 CET
COVID-19: Anti-inflammatory
20:00 CET
Roundtable Discussion and Q&A
Session 3: What About Us - Clinical Management of the Different Populations -
Brenda Crabtree Ramírez, MD
Session chairs
20:40 CET
Special Populations and COVID-19
21:00 CET
Pediatrics – Pregnancy, Breastfeeding, Multisystem Inflammatory Syndrome
21:20 CET
Infection Control: HCPs in Hospitals and Outpatient Settings
21:40 CET
COVID-19 Clinical Case
21:55 CET
Panel Discussion
Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán (INCMNSZ), Mexico
22:15 CET
Summary and Closure of the Workshop
* The program titles are subject to change without further notification.
General
What's New
- Enduring materials are available on this website.
Welcome
The Workshop on Clinical Management of COVID-19 was held virtually on 14 - 15 December 2020.
The Workshop on Clinical Management of COVID-19 aims to increase knowledge and facilitate discussion on the many remaining unknowns that healthcare providers encounter on a daily basis when caring for COVID-19 patients.
Our goal is to address the many aspects of COVID-19 including pathogenesis, epidemiology, therapeutics, and clinical management in both the outpatient as well as inpatient settings. This global program hopes to promote understanding and stimulate further discussion and research among infectious diseases specialists, pulmonologists, intensivists, epidemiologists, and community scientists.
This will be done in the truly global context of the COVID-19 pandemic, considering regional differences in access to medications, health system capacity, and public measures.
We would like to thank everyone that joined this first virtual workshop on the clinical management of COVID-19.
The Organizing Committee
Who Should Attend?
• Physicians caring for COVID-19 patients;
• Pharmacologists, nurses, and other healthcare professionals involved in the care of COVID-19 patients as well as those conducting
research on SARS-CoV2 and COVID 19;
• Healthcare administrators, policymakers, and (non)government representatives
• Pharmacologists, nurses, and other healthcare professionals involved in the care of COVID-19 patients as well as those conducting
research on SARS-CoV2 and COVID 19;
• Healthcare administrators, policymakers, and (non)government representatives
Learning Objectives
At the completion of the program participants will:
• Have a better understanding of the COVID-19 clinical manifestations;
• Obtain an updated understanding of the therapeutic options available today and those in advanced clinical trials;
• Be knowledgeable of the key aspects of clinical management of COVID 19 patients
• Have a better understanding of the COVID-19 clinical manifestations;
• Obtain an updated understanding of the therapeutic options available today and those in advanced clinical trials;
• Be knowledgeable of the key aspects of clinical management of COVID 19 patients
Committees
Support
Gilead Sciences has provided part funding for this Independent Medical Education program.
Gilead has had no input into selection of speakers or the content of the materials and presentations.
Endorsers
Language
Related Programs
